Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN969400 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Solute Carrier Family 22 (Organic Cation Transporter), Member 1 (SLC22A1) antibody
- Antibody type
- Monoclonal
- Description
- Ascites
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 2C5
- Vial size
- 100 μL
- Storage
- 4°C, -20°C for long term storage
Submitted references Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia.
OCT1 (SLC22A1) R61C polymorphism and response to imatinib treatment in chronic myeloid leukemia patients.
Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
Giannoudis A, Davies A, Lucas CM, Harris RJ, Pirmohamed M, Clark RE
Blood 2008 Oct 15;112(8):3348-54
Blood 2008 Oct 15;112(8):3348-54
OCT1 (SLC22A1) R61C polymorphism and response to imatinib treatment in chronic myeloid leukemia patients.
Zach O, Krieger O, Foedermayr M, Zellhofer B, Lutz D
Leukemia & lymphoma 2008 Nov;49(11):2222-3
Leukemia & lymphoma 2008 Nov;49(11):2222-3
Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
Hirayama C, Watanabe H, Nakashima R, Nanbu T, Hamada A, Kuniyasu A, Nakayama H, Kawaguchi T, Saito H
Pharmaceutical research 2008 Apr;25(4):827-35
Pharmaceutical research 2008 Apr;25(4):827-35
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS